IL93866A0 - Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use - Google Patents

Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use

Info

Publication number
IL93866A0
IL93866A0 IL93866A IL9386690A IL93866A0 IL 93866 A0 IL93866 A0 IL 93866A0 IL 93866 A IL93866 A IL 93866A IL 9386690 A IL9386690 A IL 9386690A IL 93866 A0 IL93866 A0 IL 93866A0
Authority
IL
Israel
Prior art keywords
purpuromycin
dosage forms
treatment
pharmaceutical dosage
vaginal infections
Prior art date
Application number
IL93866A
Other languages
English (en)
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL93866A0 publication Critical patent/IL93866A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL93866A 1989-03-31 1990-03-23 Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use IL93866A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89105686 1989-03-31
EP89109272 1989-05-23

Publications (1)

Publication Number Publication Date
IL93866A0 true IL93866A0 (en) 1990-12-23

Family

ID=26120030

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93866A IL93866A0 (en) 1989-03-31 1990-03-23 Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use

Country Status (10)

Country Link
US (1) US5141953A (de)
EP (1) EP0389924B1 (de)
JP (1) JPH02289514A (de)
KR (1) KR900013971A (de)
AT (1) ATE109978T1 (de)
AU (1) AU628946B2 (de)
CA (1) CA2013277A1 (de)
DE (1) DE69011557T2 (de)
HU (1) HU207655B (de)
IL (1) IL93866A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447813A1 (de) * 1990-02-28 1991-09-25 GRUPPO LEPETIT S.p.A. Wasserlösliche Salze von Purpuromycin und dieses enthaltende pharmazeutische Zusammensetzungen
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
WO2003056742A1 (en) * 2002-01-04 2003-07-10 Nokia Corporation High rate transmit diversity transmission and reception
EP1691743A4 (de) * 2003-11-11 2010-08-25 Univ Minnesota Regulierung von zellmembran-vermittelten wirkungen
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
MD3481370T2 (ro) 2016-07-08 2021-08-31 Acraf Compoziție farmaceutică care conţine benzidamină

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1455128A (en) * 1973-03-19 1976-11-10 Lepetit Spa Purpuromycin and its derivatives

Also Published As

Publication number Publication date
DE69011557D1 (de) 1994-09-22
EP0389924B1 (de) 1994-08-17
HU207655B (en) 1993-05-28
AU5206390A (en) 1990-10-04
US5141953A (en) 1992-08-25
CA2013277A1 (en) 1990-09-30
HUT54299A (en) 1991-02-28
JPH02289514A (ja) 1990-11-29
AU628946B2 (en) 1992-09-24
ATE109978T1 (de) 1994-09-15
EP0389924A3 (de) 1991-08-14
HU901897D0 (en) 1990-07-28
DE69011557T2 (de) 1995-03-23
KR900013971A (ko) 1990-10-22
EP0389924A2 (de) 1990-10-03

Similar Documents

Publication Publication Date Title
BR0009718A (pt) Processo de tratamento
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
DE3650741D1 (de) Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
ATE296093T1 (de) Azalid-antibiotika zur topischen behandlung oder vorbeugung okulärer infektionen
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
ZA87164B (en) Opthlamic use of quinolone and naphthyridine antibiotics
OA09917A (en) Compounds for use in treating HIV infection
IL93866A0 (en) Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use
DK312688D0 (da) Glykkopeptid-antibiotika
PT89582B (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
AU3612689A (en) Veterinary composition containing ampicillin and cloxacillin for treating eye infection
ZA902254B (en) Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use
EP0400312A3 (de) Verfahren und Zusammensetzung zur Behandlung von Protozoen-Infektionen mit einem antibakteriellen Mittel
EP0195749A3 (de) Verwendung von Benzydamin zur Behandlung von Trichomonas-vaginalis- und Gardnerella-vaginalis-Infektionen
EE03063B1 (et) Farmatseutiline salv, mis on vaba nahka ärritavast toimest ja selle valmistamise protsess
IT1236836B (it) Estere dell'acido (6r-7r)-3-carbamoilossimetil-7-(-2-(2-furil) 2-metossiimmino)acetammido)-cef-3-em-4- carbossilico, procedimento per la loro preparazione e relative composizioni.
MX9204845A (es) Combinaciones de compuestos de cloruro de amonio ymetodo para el tratamiento de infecciones virales.
RU93000551A (ru) Лекарственное средство мазь лингезин
CO4750657A1 (es) Nuevos compuestos
UA18433A (uk) Засіб для лікуваhhя іhфіковаhих раh
RU92015818A (ru) Способ для лечения энуреза
RU93047438A (ru) Способ лечения гнойно-воспалительных процессов